Posted by Michael Wonder on 01 Nov 2020
John Ivison: The math of saving lives — Canada's drug battle leaves patients caught in the middle
31 October 2020 - By cold mathematics, spending $1.3 billion to transform the lives of 3,700 Canadians might seem a poor return.
But Ron Jobbagy, father of two cystic fibrosis patients, is urging the federal government to look beyond the numbers when it comes to negotiating access to Trikafta, a life changing treatment that has been available in the U.S. for a year but has yet to enter the approval process in Canada.
